Amneal Pharmaceuticals, INC. (AMRX) SEC Filings — 2025
15 SEC filings for Amneal Pharmaceuticals, INC. (AMRX) in 2025.
Filings
- Amneal Revenue Jumps 11.7% in Q3, Refinancing Costs Hit Profit — 10-Q · Nov 6, 2025
- Amneal Pharmaceuticals Files 8-K on Financials — 8-K · Oct 30, 2025
- Amneal Pharmaceuticals Files Q2 2025 10-Q — 10-Q · Aug 7, 2025
- Amneal Pharmaceuticals Files 8-K/A Amendment — 8-K/A · Aug 5, 2025
- Amneal Pharmaceuticals Enters Material Agreement, Incurs Financial Obligation — 8-K · Aug 1, 2025
- Amneal Pharmaceuticals Files 8-K Report — 8-K · Jul 24, 2025
- Amneal Pharmaceuticals Files 8-K on Operations and Personnel — 8-K · Jul 21, 2025
- Amneal Pharmaceuticals Files 8-K Report — 8-K · Jul 21, 2025
- Amneal Pharmaceuticals Files 8-K on Shareholder Votes — 8-K · May 8, 2025
- Amneal Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 7, 2025
- Amneal Pharmaceuticals Files 8-K on Financials — 8-K · May 2, 2025
- Amneal Pharma Proxy: Exec Pay & Board Nominee Details — DEF 14A · Mar 25, 2025
- Amneal Pharmaceuticals Reports Director/Officer Changes — 8-K · Mar 6, 2025
- Amneal Pharmaceuticals Files 2024 10-K — 10-K · Feb 28, 2025
- Amneal Pharmaceuticals Files 8-K on Financials — 8-K · Jan 15, 2025